◀ Back to IL1B

IL1B — KITLG

Text-mined interactions from Literome

Da Silva et al., FASEB J 2003 : Transcription of stem cell factor (SCF) is potentiated by glucocorticoids and interleukin-1beta through concerted regulation of a GRE-like and an NF-kappaB response element
Da Silva et al., Mem Inst Oswaldo Cruz 2005 (Asthma...) : Transfection experiments with the SCF promoter including intron1 also confirm this increase and decrease of SCF expression by IL-1beta and glucocorticoids, and the potentiation by glucocorticoids of the IL-1beta induced SCF expression
Bouchelouche et al., J Urol 2006 : We investigated whether HDSMCs are capable of expressing and releasing MCP-1, IL-6 and SCF in response to IL-4, IL-13, IL-1beta and tumor necrosis factor-alpha ... Furthermore, IL-1beta and tumor necrosis factor-alpha alone induced significant release of MCP-1, IL-6 and SCF but in combination with IL-4 or IL-13 it induced greater secretion of MCP-1, IL-6 and SCF
Lin et al., Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006 (Multiple Myeloma) : There were obviously differences of IL-1beta expression between refractory/relapsed group and complete remission ( CR ) group and IL-1beta expression was inhibited more seriously in CR group, whereas there were no significant differences of IL-6 and SCF expression between two groups ; IL-1beta expression of patients treated with PS-341 was not detected ; there were not effects of IL-1beta expression on expressions of IL-6 and SCF
Kim et al., Toxicol Appl Pharmacol 2007 : In addition, production of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta , and vascular endothelial growth factor ( VEGF ) production induced by SCF was significantly inhibited by treatment with SC-236
Bonsi et al., Stem Cells 1993 (Fanconi Anemia) : Interleukin 1 beta (IL-1 beta) induced a significant increase of soluble SCF from both normal and DBA BMEF